CXCR4 and neoplasm: While taxol treatment even enhanced the SDF-1 expression in MSC, the derived EV/exosome-associated SDF-1 may also contribute at least partially to the activation of the CXCR4 and/or CXCR7 receptors on target cells of several tumor populations.